title: Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child.
abstract: Congenital optic nerve abnormalities may rarely cause choroidal neovascularization (CNV). This case report summarizes the clinical and therapeutic outcomes of a 7-year-old boy with unilateral CNV secondary to morning glory syndrome associated with acute visual acuity loss. The patient was successfully treated with a single intravitreal ranibizumab injection. One month after the injection the visual acuity increased and optic coherence tomography (OCT) showed a decrease in the intraretinal fluid around the CNV. The patient was then called for monthly follow-up visits. No further treatment was needed for the next 12 months after the first treatment. There was no complication related to the injection.
authors.affiliation: Beyoğlu Eye Research and Training Hospital, Beyoğlu, İstanbul, Turkey.
authors.forename: Abdullah
authors.initials: A
authors.lastname: Özkaya
authors.affiliation: Beyoğlu Eye Research and Training Hospital, Beyoğlu, İstanbul, Turkey.
authors.forename: Ihsan
authors.initials: I
authors.lastname: Yilmaz
authors.affiliation: Beyoğlu Eye Research and Training Hospital, Beyoğlu, İstanbul, Turkey.
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Alkin
authors.affiliation: Beyoğlu Eye Research and Training Hospital, Beyoğlu, İstanbul, Turkey.
authors.forename: Yalcin
authors.initials: Y
authors.lastname: Karakucuk
authors.affiliation: Beyoğlu Eye Research and Training Hospital, Beyoğlu, İstanbul, Turkey.
authors.forename: Ahmet Taylan
authors.initials: AT
authors.lastname: Yazici
keywords: Choroidal neovascularization; Morning glory syndrome; Ranibizumab